Cobblestone Capital Advisors LLC NY raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 4.6% during the second quarter, according to the company in its most recent ...

Carillon Eagle Growth & Income Fund highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the second quarter 2024 investor letter. AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other 52-week high stocks. The U.S. stock market has been on a roll, with major indices ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that add up to a wide moat. The strong replenishment of new drugs ...

Qiagen and AstraZeneca are expanding their diagnostics partnership, with plans to explore the use of genomic profiling in chronic diseases beyond cancer. The long-time collaborators, which ...

AstraZeneca has beaten all healthcare-focused ETFs. The stock is up by over 27% this year, helped by its oncology business. It has gotten highly overbought, meaning that a pullback is coming ...

Chris Nemeth, 51, worked in airline logistics until he got the AstraZeneca vaccine in July 2021 and developed chronic inflammatory demyelinating polyneuropathy (CIPD) which can cause numbness ...

As­traZeneca is spend­ing $135 mil­lion to ex­pand a bi­o­log­ics fa­cil­i­ty in Swe­den due to an in­crease in de­mand for its pre-filled sy­ringe drug prod­ucts, a … ...

British pharma giant AstraZeneca plans to spend $135 million to expand the manufacturing operations footprint of its site in Södertälje, Sweden, by 50%. The project calls for a 2,700-square ...

AstraZeneca’s anti-platelet drug Brilinta has been cleared in the US for a major new indication, preventing a first heart attack or stroke in high-risk patients with coronary artery disease (CAD).